Xiaoming Zha
- Cancer Research top 10%
- Breast Cancer Treatment Studies 21
- Nephrology top 5%
- Parathyroid Disorders and Treatments 9
- Oncology top 10%
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 7
- Cancer Risks and Factors 4
- Cancer Cells and Metastasis 4
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 9
-
- Thyroid and Parathyroid Surgery 4
- Cited by
- Cancer ResearchNephrologyOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoming Zha
52 papers receiving 889 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 287
- Nephrology 102
- Oncology 290
- Pathology and Forensic Medicine 175
- Biochemistry 30
Countries citing papers authored by Xiaoming Zha
This map shows the geographic impact of Xiaoming Zha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Zha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Zha more than expected).
Fields of papers citing papers by Xiaoming Zha
This network shows the impact of papers produced by Xiaoming Zha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Zha. The network helps show where Xiaoming Zha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoming Zha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 2 | |
| 12 | 2019 | 19 | |
| 13 | 2019 | 7 | |
| 14 | 2017 | 11 | |
| 15 | 2016 | 3 | |
| 16 | 2013 | 24 | |
| 17 | 2012 | 35 | |
| 18 | 2012 | 75 | |
| 19 | 2012 | 17 | |
| 20 | 2010 | 24 |
About Xiaoming Zha
Xiaoming Zha is a scholar working on Cancer Research, Nephrology and Oncology, having authored 58 papers that have together received 902 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), Parathyroid Disorders and Treatments (9 papers), Breast Lesions and Carcinomas (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Risks and Factors (4 papers), Cancer Cells and Metastasis (4 papers) and Thyroid and Parathyroid Surgery (4 papers). The work is most often cited by research in Cancer Research (287 citations), Nephrology (102 citations) and Oncology (290 citations). Xiaoming Zha has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoan Liu, Wenbin Zhou, Qiang Ding, Shui Wang, Lijun Ling, Shui Wang, Wei He, Hong Pan, Xiaojian Ni and Yingchun Zhao. Their work appears in journals such as PLoS ONE, Cancer Research and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.